Giuseppe Andò: Stable CAD + Oral Anticoagulation: Is Combination Therapy Still Justified?
Giuseppe Andò, Head of the Cardiology Department at Papardo University Hospital, shared on LinkedIn:
” Stable CAD + Oral Anticoagulation: Is Combination Therapy Still Justified?
For years, adding antiplatelet therapy to oral anticoagulation has been considered “safer.”
The evidence no longer supports this approach.
In the post-AQUATIC era, leveraging data from a large European RCT that expanded indications for OAC beyond atrial fibrillation, we conducted an updated meta-analysis of 6 randomized trials (n = 5,924) comparing OAC monotherapy vs OAC + SAPT in stable coronary artery disease.
OAC monotherapy delivers:
−51% major bleeding
Lower net adverse clinical events
Reduced cardiovascular mortality
No increase in ischemic events
Even more compelling: DOAC-based monotherapy significantly reduced MACE, with a clear treatment interaction.
Bottom line:
In patients with stable CAD requiring long-term anticoagulation, less is more.
OAC monotherapy—particularly with DOACs—should be the default strategy, especially in East Asian populations.
After AQUATIC, continuing routine combination therapy deserves serious reconsideration.”
Title: Oral anticoagulation with versus without antiplatelet therapy in patients with stable coronary artery disease and an indication for anticoagulation: a meta-analysis with trial sequential analysis
Authors: Ahmed Ibrahim, Ali Saad Al-Shammari, Shrouk Ramadan, Yousif Hameed Kurmasha, Khadeeja Ali Hamzah, M Rafiqul Islam, Muhammad Younas, Hritvik Jain, Yasar Sattar, Pierre Sabouret and Giuseppe Andò.

Read the full article.
Stay updated with Hemostasis Today.
-
Nov 21, 2026, 20:00Jeyda Star: The FAST Signs of Stroke and the Reality of Life Afterward
-
Nov 21, 2026, 19:59Daniel Lindholm: Women Showed the Largest Improvement in Stroke Risk Over Time in Heart Failure
-
Nov 21, 2026, 19:56Neil Arrowsmith: Raising Awareness of Pulmonary Embolism in Young People
-
Nov 21, 2026, 19:52Muhammad Zeeshan Jamal: Thrilled to Present Our Research on Intermediate-Risk Acute PE in Abu Dhabi
-
Nov 21, 2026, 19:50Mounisha Devireddy: Proud to Share Our Research on High-Risk PE in Pregnancy
-
Nov 21, 2026, 19:47Melissa Hollo: How Severe Anemia Increases the Odds of Acute HF During Pregnancy and Postpartum
-
Nov 21, 2026, 19:44Ashenafi Tazebew Amare: Building Sustainable Systems to Close the Anti-D Immunoglobulin Access Gap in LMICs
-
Nov 21, 2026, 19:43Sheharyar Raza: Interpreting Clotting Times Through Reptilase Time and Thrombin Time Assays
-
Nov 21, 2026, 19:42Minoo Ahmadinejad: Serving on the ISTH 2027 Scientific Theme Committee for Women’s Health